![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | A61K 31/522 | (2006.01) |
A61K 31/519 | (2006.01) | ||
A61P 25/28 | (2006.01) |
(11) | Number of the document | 2200616 |
(13) | Kind of document | T |
(96) | European patent application number | 08794174.6 |
Date of filing the European patent application | 2008-08-22 | |
(97) | Date of publication of the European application | 2010-06-30 |
(45) | Date of publication and mention of the grant of the patent | 2012-12-26 |
(46) | Date of publication of the claims translation | 2013-03-25 |
(86) | Number | PCT/SE2008/050950 |
Date | 2008-08-22 |
(87) | Number | WO 2009/025618 |
Date | 2009-02-26 |
(30) | Number | Date | Country code |
957525 P | 2007-08-23 | US | |
957523 P | 2007-08-23 | US |
(72) |
ERIKSSON, Håkan, SE
POEWE, Werner, AT
|
(73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
(74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
(54) | MIPO slopikliai, skirti Huntingtono ligos ir dauginės sisteminės atrofijos gydymui |
MIPO INHIBITORS FOR THE TREATMENT OF HUNTINGTON`S DISEASE AND MULTIPLE SYSTEM ATROPHY |
Payment date | Validity (years) | Amount | |
2016-07-18 | 9 | 208.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2017-08-22 |